Citadel Advisors
PROF

Citadel Advisors’s Profound Medical PROF Stock Holding History

Citadel Advisors’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,073
Closed -$50.2K – 13765
2025
Q3 		$50.2K Sell
10,073
-36,237
-78% -$185K ﹤0.01% 12208
2025
Q2 		$273K Sell
46,310
-26,011
-36% -$138K ﹤0.01% 10004
2025
Q1 		$421K Buy
72,321
+26,230
+57% +$181K ﹤0.01% 8861
2024
Q4 		$346K Buy
46,091
+19,146
+71% +$147K ﹤0.01% 9364
2024
Q3 		$214K Buy
+26,945
New +$243K ﹤0.01% 10002
2024
Q2 		– Sell
-10,607
Closed -$90.5K – 15139
2024
Q1 		$90.5K Sell
10,607
-9,111
-46% -$76K ﹤0.01% 11491
2023
Q4 		$167K Buy
19,718
+18,809
+2,069% +$179K ﹤0.01% 10221
2023
Q3 		$9.27K Sell
909
-11,285
-93% -$117K ﹤0.01% 13137
2023
Q2 		$159K Buy
+12,194
New +$151K ﹤0.01% 10250
2022
Q1 		– Sell
-33,343
Closed -$321K – 14362
2021
Q4 		$374K Buy
33,343
+6,535
+24% +$81.6K ﹤0.01% 10404
2021
Q3 		$392K Sell
26,808
-5,639
-17% -$85.9K ﹤0.01% 10455
2021
Q2 		$531K Sell
32,447
-49,466
-60% -$920K ﹤0.01% 9932
2021
Q1 		$1.65M Buy
81,913
+48,138
+143% +$1.15M ﹤0.01% 6869
2020
Q4 		$694K Buy
33,775
+10,692
+46% +$197K ﹤0.01% 7515
2020
Q3 		$407K Buy
+23,083
New +$367K ﹤0.01% 7634
2020
Q2 		– Sell
-19,234
Closed -$187K – 10348
2020
Q1 		$187K Buy
+19,234
New +$249K ﹤0.01% 8077

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $127M AUM 23.73% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
ZCP
Z3 Capital Partners Richmond, Virginia $395M AUM
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Citadel Advisors's PROF Position: Q4 2025 in Review

Citadel Advisors sold out of Profound Medical (PROF) in Q4 2025, closing a stake of 10,073 shares — an estimated $50.2K sold.

Citadel Advisors first reported a position in PROF in Q1 2020 and held it in 16 quarters. The position peaked at $1.65M in Q1 2021. 63 funds tracked by Wall St. Rank hold PROF as of Q4 2025.

  • Citadel Advisors reported no remaining Profound Medical position as of Q4 2025 after selling out during the quarter.
  • Citadel Advisors sold 10,073 Profound Medical shares in Q4 2025, an estimated $50.2K.
  • Citadel Advisors first reported a position in Profound Medical in Q1 2020 and held it in 16 quarters.
  • Citadel Advisors's Profound Medical position peaked at $1.65M in Q1 2021.
  • 63 funds tracked by Wall St. Rank held Profound Medical as of Q4 2025.

Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.